Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 1/20 | 0.56 |
| ▸ | REN | P00797 | 5/20 | 0.54 |
| ▸ | BACE1 | P56817 | 2/20 | 0.50 |
| ▸ | HLA-DRB1 | P01911 | 1/20 | 0.48 |
| ▸ | CTSC | P53634 | 1/20 | 0.47 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29947748 | 0.87 | CTSC (0.59) | CALCRLRENCTSCPSMB5 | |
| SCHEMBL30638996 | 0.87 | REN (0.50) | CALCRLRENBACE1 | |
| SCHEMBL9642398 | 0.86 | CALCRL (0.56) | CALCRLRENBACE1HLA-DRB1CTSC | |
| SCHEMBL8953885 | 0.86 | CALCRL (0.56) | CALCRLRENBACE1HLA-DRB1CTSC | |
| SCHEMBL18568248 | 0.86 | CALCRL (0.56) | CALCRLRENBACE1HLA-DRB1CTSC | |
| SCHEMBL29958630 | 0.86 | REN (0.58) | RENCTSCPSMB5 | |
| SCHEMBL30052854 | 0.86 | CTSC (0.56) | RENCTSCPSMB5 | |
| SCHEMBL29357733 | 0.86 | REN (0.57) | REN | |
| SCHEMBL2194690 | 0.85 | REN (0.53) | CALCRLRENBACE1CTSCPSMB5 | |
| SCHEMBL30053097 | 0.85 | CTSC (0.57) | CALCRLRENBACE1HLA-DRB1CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618835-B2 | Multiplex microelectrode array for detection of proteases as biomarkers | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-20220349880-A1 | MULTIPLEX MICROELECTRODE ARRAY FOR DETECTION OF PROTEASES AS BIOMARKERS | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA | 2022-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618835-B2 | Multiplex microelectrode array for detection of proteases as biomarkers | APAF1, ADAM33, UCHL1 | CALCRL 213/4885REN 1602/4885BACE1 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.